Alerts will be sent to your verified email
Verify Email
KREBSBIO
|
Krebs Biochem.&Inds
|
Achyut Healthcare
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
37.05 % | 1.93 % | 27.3 % |
|
5yr average Equity Multiplier
|
-2.13 | 1.21 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.3 | 0.29 | 1.43 |
|
5yr Avg Net Profit Margin
|
-55.19 % | 7.92 % | 11.03 % |
|
Price to Book
|
0.0 | 3.93 | 0.55 |
|
P/E
|
0.0 | 224.81 | 13.91 |
|
5yr Avg Cash Conversion Cycle
|
-1144.52 Days | 36.15 Days | 154.28 Days |
|
Inventory Days
|
102.59 Days | 38.82 Days | 87.41 Days |
|
Days Receivable
|
8.23 Days | 105.12 Days | 103.86 Days |
|
Days Payable
|
623.06 Days | 84.53 Days | 63.18 Days |
|
5yr Average Interest Coverage Ratio
|
-4.97 | 272.88 | 57.05 |
|
5yr Avg ROCE
|
-23.43 % | 2.78 % | 36.52 % |
|
5yr Avg Operating Profit Margin
|
-34.39 % | -2.63 % | 16.64 % |
|
5 yr average Debt to Equity
|
-1.88 | 0.0 | 0.09 |
|
5yr CAGR Net Profit
|
-0.84 % | 122.88 % | -5.76 % |
|
5yr Average Return on Assets
|
-16.47 % | 1.5 % | 18.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.74 % | 47.71 % | 65.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.02 % | -18.47 % | -6.7 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Krebs Biochem.&Inds
|
Achyut Healthcare
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
Therapeutic Area Break-Up
|